Bookmark

Add to MyYahoo RSS

Teva Pharmaceutical Industries News

News on Teva Pharmaceutical Industries (Ticker: TEVA) continually updated from thousands of sources around the net.

4 hrs ago | AmericanBankingNews.com

Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Ltd announced a quarterly dividend on Friday, August 1st, Analyst Ratings Network reports.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry

Thu Jul 31, 2014

Seeking Alpha

Teva Pharmaceutical Industries' (TEVA) CEO Erez Vigodman on Q2 2014...

At this time, all participants are in a listen only mode. There will be a presentation followed by a question-and-answer session.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Cephalon, Pharmaceuticals, Healthcare Industry

The Washington Post

Teva Second-Quarter Profit Rises on New Version of MS Medicine

Teva Pharmaceutical Industries Ltd.'s raised its profit forecast and reported second-quarter earnings that beat analyst estimates as the company converted patients to a longer-acting version of the branded multiple sclerosis treatment Copaxone.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Cephalon, Pharmaceuticals, Healthcare Industry, Business News

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

El term... )--Frontier Secure, a service of Frontier Communications Corporation , is now enabling customers to share and connect to content wherever they go.

Comment?

Related Topix: Frontier Communications, Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Orange County, CA

Wed Jul 30, 2014

Reuters

Teva says shareholders favor management as shakeup fizzles

Israeli drugmaker Teva Pharmaceuticals Industries said on Wednesday it turned back efforts by Israeli industrialist Benny Landa to shake up the company's board of directors, with shareholders approving all of the company's proposals and board nominations.

Comment?

Related Topix: Biotech

Seeking Alpha

Novartis: The Case Of The Undervalued Biosimilar Pioneer

Most investors, specially when they start looking at this sector, find themselves overwhelmed with information and technical jargon.

Comment?

Related Topix: Biotech, Novartis, Medicine, Healthcare Industry, Hispanic Broadcasting, Television, Amgen

Business Wire

All Proposals Approved at Teva's Annual Meeting of Shareholders

These proposals included the appointment of directors, the approval of cash bonus objectives and future equity awards for the Chief Executive Officer, directors' and officers' insurance and the appointment of auditors.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Corporate Governance, Marketing

Forbes.com

Teva Pharmaceutical Industries EPS Estimates Improved In Past Month

Leading up to Teva Pharmaceutical Industries' announcement of its second-quarter earnings on Thursday, July 31, 2014, analysts have become more bullish as expectations have improved over the past month from $1.17 per share to the current projection of earnings of $1.22 per share.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Cephalon, Pharmaceuticals, Healthcare Industry, Financial Markets

Tue Jul 29, 2014

Seeking Alpha

Catalent IPO Should Rock Given Blackstone Backing

CTLT is a leader in a field with massive barriers to entry; and has done particularly well under Blackstone's leadership .

Comment?

Related Topix: Somerset, NJ, Blackstone Group, Advertising, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Pfizer

Fri Jul 25, 2014

Seeking Alpha

Arena Sees Belviq Sales Climb Despite Seasonality

Sales of the anti-obesity drug, Belviq, from Arena Pharmaceuticals seem to be trying to buck the trend in seasonality in the anti-obesity sector.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals

Thu Jul 24, 2014

BioSpace

Protalix Biotherapeutics, Inc. Names As Chairman Of The Board Of Directors

Protalix BioTherapeutics, Inc. , announced today that it has chosen Mr. Shlomo Yanai as Chairman of the Company's Board of Directors, effective on July 24, 2014.

Comment?

Related Topix: Frank Sinatra, Jazz, Plains Resources, Oil & Gas, Energy, Teva Pharmaceutical Industries, Biotech, Medicine, Pharmaceuticals, Healthcare Industry, MakhteshimAgan Industries, Chemicals, World News, Brazil

Freshnews

Medication Non-Adherence Issue Highlighted in Annals of Internal...

MedVantx, Inc., the company that has built an innovative new direct-to-consumer prescription delivery channel in physician offices, MedStart Connect, today announced it eliminates many of the underlying issues related to medication non-adherence and hospital readmission rates specified in a study published in a recent issue of the Annals of ... (more)

Comment?

Related Topix: Heart Attack, Health, Biotech, Medicine, Marketing

Hispanic Business

Leading U.S. Proxy Advisory Firm Supports Teva Nominees and Other Shareholders' Meeting Proposals

ISS provides voting analysis on more than 20,000 shareholder meetings per year to mutual funds, financial institutions and hedge funds.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Healthcare Industry, Pharmaceuticals

Wed Jul 23, 2014

GuruFocus.com

George Soros Reveals His Largest Stake

Over the past days hedge funds have been filing their form 13-F, which is a quarterly report of equity holdings by filed institutional investment managers with at least $100 million in equity assets under management, as required by the United States Securities and Exchange Commission .

Comment?

Related Topix: Securities and Exchange Commission, Corporate / Securities Law, Law, Soros Fund Management, Financial Services, Investment Services, Biotech

SchaeffersResearch.com

Analyst Update: EMC Corporation, Teva Pharmaceutical Industries Ltd...

"I don't know another tech company that has [spun off one of its most strategic assets] and been successful," opined EMC CEO Joe Tucci in a conference call.

Comment?

Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Pharmaceuticals, Healthcare Industry, Computers, EMC, VMware, Software, Financial Markets, Day Trading, Personal Finance

TheStreet.com

How Teva Pharmaceutical Is Attacking the Generics to Defend Its Turf

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Biotech, Mozilla

Tue Jul 22, 2014

Seeking Alpha

XTL Hopes To Begin Major Lupus Trial Next Year

XTLB is aiming to begin a Phase 2b clinical trial in the first half of 2015 with its hCDR1 peptide to treat patients with SLE.

Comment?

Related Topix: Medicine, Lupus, Health, Biotech

Freshnews

Antares Pharma Announces First Patient Dosed in Phase 3 QuickShot...

Antares Pharma, Inc. today announced that the first patient has been dosed in a double-blind, multiple-dose, phase 3 study to evaluate the efficacy and safety of QuickShot Testosterone administered subcutaneously once each week to testosterone-deficient adult males.

Comment?

Related Topix: Antares Pharma, Medicine, Medical Equipment, Healthcare Industry, Food and Drug Administration, Biotech

Mon Jul 21, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

The acquisition of Labrys brings to Teva LBR-101,... )--Mark Cosby joins Office Depot, Inc. as president, North America following a successful 30-year career at a number of leading retail chains.

Comment?

Related Topix: Biotech

San Diego Source

Arena subsidiary enters agreement with Israeli distributor for weight loss drug

Arena Pharmaceuticals Inc . announced on Monday that its wholly owned subsidiary, Arena Pharmaceuticals GmbH, has entered into an exclusive marketing and supply agreement with Abic Marketing Limited, a Teva Pharmaceutical Industries subsidiary, for its weight loss and management product Belviq.

Comment?

Related Topix: Israel, World News, Middle East, Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Marketing

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••